EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Bioprinted platform for parallelized screening of engineered microtissues in vivo

Colleen E O'Connor, Fan Zhang, Anna Neufeld, Olivia Prado, Susana P Simmonds, Chelsea L Fortin, Fredrik Johansson, Jonathan Mene, Sarah H Saxton, Irina Kopyeva, Nicole E Gregorio, Zachary James und 4 weitere

Cell Stem Cell · 2025

DOI: 10.1016/j.stem.2025.03.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Stem Cell, 2025. Verfasst von Colleen E O'Connor und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Washington, Seattle, WA 98195, USA; Institute for Stem Cell and Regenerative Medicine, Seattle, WA 98195,…. Hauptthemen laut MEDLINE: Tissue Engineering, Bioprinting, Printing, Three-Dimensional. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, NIDDK NIH HHS, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human engineered tissues hold great promise for therapeutic tissue regeneration and repair. Yet, development of these technologies often stalls at the stage of in vivo studies due to the complexity of engineered tissue formulations, which are often composed of diverse cell populations and material elements, along with the tedious nature of in vivo experiments. We introduce a "plug and play" platform called parallelized host apposition for screening tissues in vivo (PHAST). PHAST enables parallelized in vivo testing of 43 three-dimensional microtissues in a single 3D-printed device. Using PHAST, we screen microtissue formations with varying cellular and material components and identify formulations that support vascular graft-host inosculation and engineered liver tissue function in vivo. Our studies reveal that the cellular population(s) that should be included in engineered tissues for optimal in vivo performance is material dependent. PHAST could thus accelerate development of human tissue therapies for clinical regeneration and repair.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tissue EngineeringBioprintingPrinting, Three-DimensionalHumansAnimalsMiceTissue ScaffoldsLiver

Stichwörter der Autor:innen

3D printingbiomaterialbioprintinghigh-throughputhydrogelin vivolivermicroenvironmenttissue engineeringvascularization

Autor:innen und Institutionen

  • Department of Bioengineering, University of Washington, Seattle, WA 98195, USA; Institute for Stem Cell and Regenerative Medicine, Seattle, WA 98195, USA.
  • Department of Statistics, University of Washington, Seattle, WA, USA.
  • Department of Bioengineering, University of Washington, Seattle, WA 98195, USA; Institute for Stem Cell and Regenerative Medicine, Seattle, WA 98195, USA; Department of Laboratory Medicine & Pathology, University of Was…
  • Department of Bioengineering, University of Washington, Seattle, WA 98195, USA.
  • Department of Bioengineering, University of Washington, Seattle, WA 98195, USA; Institute for Stem Cell and Regenerative Medicine, Seattle, WA 98195, USA; Department of Chemical Engineering, University of Washington, Se…
  • Department of Statistics, University of Washington, Seattle, WA, USA; Department of Biostatistics, University of Washington, Seattle, WA, USA.

Förderung

  • NIGMS NIH HHS
  • NIDDK NIH HHS
  • Wellcome Trust
  • NCATS NIH HHS
  • W. M. Keck Foundation
  • National Institutes of Health
  • National Center for Advancing Translational Sciences
  • National Science Foundation

Zitieren

APA

O'Connor, C. E., Zhang, F., Neufeld, A., Prado, O., Simmonds, S. P., Fortin, C. L., Johansson, F., Mene, J., Saxton, S. H., Kopyeva, I., Gregorio, N. E., James, Z., DeForest, C. A., Wayne, E. C., Witten, D. M., & Stevens, K. R. (2025). Bioprinted platform for parallelized screening of engineered microtissues in vivo. Cell Stem Cell. https://doi.org/10.1016/j.stem.2025.03.002

Vancouver

O'Connor CE, Zhang F, Neufeld A, Prado O, Simmonds SP, Fortin CL, et al. Bioprinted platform for parallelized screening of engineered microtissues in vivo. Cell Stem Cell. 2025. doi:10.1016/j.stem.2025.03.002

BibTeX
@article{OConnor2025,
  author = {O'Connor, Colleen E and Zhang, Fan and Neufeld, Anna and Prado, Olivia and Simmonds, Susana P and Fortin, Chelsea L and Johansson, Fredrik and Mene, Jonathan and Saxton, Sarah H and Kopyeva, Irina and Gregorio, Nicole E and James, Zachary and DeForest, Cole A and Wayne, Elizabeth C and Witten, Daniela M and Stevens, Kelly R},
  title = {Bioprinted platform for parallelized screening of engineered microtissues in vivo},
  journal = {Cell Stem Cell},
  year = {2025},
  doi = {10.1016/j.stem.2025.03.002}
}
Kostenlos starten →